APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 1 6 2020
medline: 8 5 2021
entrez: 1 6 2020
Statut: ppublish

Résumé

Episodic memory decline is one of the earliest symptoms of late-onset Alzheimer's disease (AD). Older adults with the apolipoprotein E ɛ4 (+APOE4) genetic risk factor for AD may exhibit altered patterns of memory-related brain activity years prior to initial symptom onset. Here we report the baseline episodic memory task functional MRI results from the PRe-symptomatic EValuation of Experimental or Novel Treatments for Alzheimer's Disease cohort in Montreal, Canada, in which 327 healthy older adults were scanned within 15 years of their parent's conversion to AD. Volunteers were scanned as they encoded and retrieved object-location spatial source associations. The task was designed to discriminate between brain activity related to spatial source recollection and object-only (recognition) memory. We used multivariate partial least squares (PLS) to test the hypothesis that +APOE4 adults with family history of AD would exhibit altered patterns of brain activity in the recollection-related memory network, comprised of medial frontal, parietal, and medial temporal cortices, compared to APOE4 non-carriers (-APOE4). We also examined group differences in the correlation between event-related brain activity and memory performance. We found group similarities in memory performance and in task-related brain activity in the recollection network, but differences in brain activity-behavior correlations in ventral occipito-temporal, medial temporal, and medial prefrontal cortices during episodic encoding. These findings are consistent with previous literature on the influence of APOE4 on brain activity and provide new perspective on potential gene-based differences in brain-behavior relationships in people with first-degree family history of AD.

Sections du résumé

BACKGROUND
Episodic memory decline is one of the earliest symptoms of late-onset Alzheimer's disease (AD). Older adults with the apolipoprotein E ɛ4 (+APOE4) genetic risk factor for AD may exhibit altered patterns of memory-related brain activity years prior to initial symptom onset.
OBJECTIVE
Here we report the baseline episodic memory task functional MRI results from the PRe-symptomatic EValuation of Experimental or Novel Treatments for Alzheimer's Disease cohort in Montreal, Canada, in which 327 healthy older adults were scanned within 15 years of their parent's conversion to AD.
METHODS
Volunteers were scanned as they encoded and retrieved object-location spatial source associations. The task was designed to discriminate between brain activity related to spatial source recollection and object-only (recognition) memory. We used multivariate partial least squares (PLS) to test the hypothesis that +APOE4 adults with family history of AD would exhibit altered patterns of brain activity in the recollection-related memory network, comprised of medial frontal, parietal, and medial temporal cortices, compared to APOE4 non-carriers (-APOE4). We also examined group differences in the correlation between event-related brain activity and memory performance.
RESULTS
We found group similarities in memory performance and in task-related brain activity in the recollection network, but differences in brain activity-behavior correlations in ventral occipito-temporal, medial temporal, and medial prefrontal cortices during episodic encoding.
CONCLUSION
These findings are consistent with previous literature on the influence of APOE4 on brain activity and provide new perspective on potential gene-based differences in brain-behavior relationships in people with first-degree family history of AD.

Identifiants

pubmed: 32474466
pii: JAD191292
doi: 10.3233/JAD-191292
pmc: PMC7369116
doi:

Substances chimiques

Apolipoprotein E4 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-119

Références

Neuropsychol Rev. 2012 Sep;22(3):298-309
pubmed: 22359096
Biol Psychiatry. 2013 Sep 1;74(5):375-83
pubmed: 23726515
J Neurosci. 2011 Dec 7;31(49):17941-54
pubmed: 22159109
J Neurosci. 2003 Feb 1;23(3):986-93
pubmed: 12574428
Front Aging Neurosci. 2018 Nov 13;10:342
pubmed: 30483113
Neurobiol Aging. 2013 Feb;34(2):361-73
pubmed: 22592018
J Neurosci. 2012 Aug 1;32(31):10749-57
pubmed: 22855822
Neuromolecular Med. 2010 Mar;12(1):27-43
pubmed: 20069392
J Neurosci. 2006 May 31;26(22):6069-76
pubmed: 16738250
Brain Imaging Behav. 2017 Feb;11(1):194-204
pubmed: 26843007
Neurobiol Aging. 2014 Jul;35(7):1615-23
pubmed: 24582638
Neuropsychologia. 2013 Oct;51(12):2450-61
pubmed: 23831717
Lancet Neurol. 2019 Jan;18(1):88-106
pubmed: 30497964
Alzheimers Res Ther. 2017 Sep 12;9(1):71
pubmed: 28899416
J Alzheimers Dis. 2018;63(2):577-590
pubmed: 29660934
Neuropsychol Rev. 2014 Sep;24(3):332-54
pubmed: 25119304
Brain. 2020 Feb 1;143(2):635-649
pubmed: 32040564
Lancet Neurol. 2018 May;17(5):434-444
pubmed: 29555425
Curr Opin Neurobiol. 2006 Dec;16(6):693-700
pubmed: 17097284
Int Rev Psychiatry. 2013 Dec;25(6):673-85
pubmed: 24423221
Lancet. 2017 Dec 16;390(10113):2614-2615
pubmed: 28735854
J Prev Alzheimers Dis. 2016;3(4):229-235
pubmed: 29034223
Psychol Med. 2011 Sep;41(9):1997-2006
pubmed: 21284913
Neuroimage. 1996 Jun;3(3 Pt 1):143-57
pubmed: 9345485
Neurology. 2005 Aug 23;65(4):559-64
pubmed: 16116116
Hum Brain Mapp. 1997;5(5):329-40
pubmed: 20408237
Neurobiol Aging. 2012 Feb;33(2):425.e3-18
pubmed: 21111514
J Neurosci. 2016 Aug 10;36(32):8390-8
pubmed: 27511011
Curr Opin Neurobiol. 2013 Apr;23(2):255-60
pubmed: 23206590
Neurosci Biobehav Rev. 2014 Sep;45:246-57
pubmed: 24973756
Hum Brain Mapp. 2018 Feb;39(2):971-984
pubmed: 29164798
Alzheimers Dement. 2010 Jul;6(4):303-11
pubmed: 19744893
Int J Psychophysiol. 2020 Aug;154:15-26
pubmed: 30936043
Alzheimers Dement. 2009 May;5(3):215-26
pubmed: 19362885
Alzheimers Dement. 2015 Jul;11(7):730-3
pubmed: 26194308
J Cogn Neurosci. 2019 Dec;31(12):1895-1916
pubmed: 31393233
J Neurophysiol. 2006 Oct;96(4):1902-11
pubmed: 16738210
Neuroimage. 2016 Oct 1;139:103-113
pubmed: 27311641
Transl Psychiatry. 2018 Jan 10;8(1):18
pubmed: 29317609
J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9
pubmed: 9845158
Cortex. 2018 Jul;104:103-123
pubmed: 29800787
Continuum (Minneap Minn). 2019 Feb;25(1):14-33
pubmed: 30707185
Philos Trans R Soc Lond B Biol Sci. 2001 Sep 29;356(1413):1351-61
pubmed: 11571027
Front Aging Neurosci. 2013 Dec 11;5:89
pubmed: 24376418
Neuroimage Clin. 2017 Mar 31;14:760-774
pubmed: 28413778
PLoS One. 2014 Sep 11;9(9):e106953
pubmed: 25211489
Neuroimage. 2014 Apr 1;89:81-91
pubmed: 24296331
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Curr Opin Neurobiol. 2011 Dec;21(6):929-34
pubmed: 22079495
Hum Brain Mapp. 2007 Nov;28(11):1194-205
pubmed: 17266101
Neurobiol Aging. 2017 Dec;60:20-33
pubmed: 28917664
N Engl J Med. 2012 Aug 30;367(9):795-804
pubmed: 22784036
Brain. 2006 May;129(Pt 5):1229-39
pubmed: 16627465
Curr Alzheimer Res. 2018;15(8):702-715
pubmed: 29359668
Curr Alzheimer Res. 2019;16(1):67-89
pubmed: 30345915
Brain. 2001 Jan;124(Pt 1):96-102
pubmed: 11133790
Hum Brain Mapp. 2009 Sep;30(9):2907-26
pubmed: 19172646
Neuroimage. 2004;23 Suppl 1:S250-63
pubmed: 15501095
Brain. 2018 Jun 1;141(6):1871-1883
pubmed: 29688388
Neuroimage. 2011 May 15;56(2):455-75
pubmed: 20656037
Neurology. 2008 May 6;70(19 Pt 2):1842-9
pubmed: 18401023
J Prev Alzheimers Dis. 2016;3(4):236-242
pubmed: 29199324
Dialogues Clin Neurosci. 2002 Jun;4(2):197-210
pubmed: 22033483
Pharmacol Ther. 2019 Jul;199:173-187
pubmed: 30877021
Magn Reson Imaging. 2012 Apr;30(3):446-52
pubmed: 22227352
Int Psychogeriatr. 2019 Apr;31(4):491-504
pubmed: 30426911
Neurochirurgia (Stuttg). 1958 Jun;1(1):88-93
pubmed: 13578055
J Geriatr Psychiatry Neurol. 2020 May;33(3):155-160
pubmed: 31500493
Alzheimers Dement. 2018 Feb;14(2):121-129
pubmed: 29233480
J Neurosci. 2008 Nov 26;28(48):12820-4
pubmed: 19036975
PLoS One. 2011 Feb 18;6(2):e16852
pubmed: 21364746
Behav Res Methods Instrum Comput. 1999 Feb;31(1):137-49
pubmed: 10495845
Dev Cogn Neurosci. 2016 Aug;20:59-69
pubmed: 27434313
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7209-14
pubmed: 19357304
JAMA Neurol. 2018 May 1;75(5):608-619
pubmed: 29482212
Cortex. 2010 Apr;46(4):535-49
pubmed: 19674742
Neuropsychologia. 2019 Oct;133:107180
pubmed: 31473197
Brain. 2009 Feb;132(Pt 2):383-91
pubmed: 18829694
Alzheimers Dement (N Y). 2016 Mar 03;2(2):82-92
pubmed: 29067295
Neurology. 2018 May 8;90(19):e1682-e1691
pubmed: 29653987
Br J Psychiatry. 1984 Sep;145:339
pubmed: 6478132
Dev Psychol. 2013 May;49(5):973-85
pubmed: 22686174
Hum Brain Mapp. 2013 Dec;34(12):3308-19
pubmed: 22806961
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):828-33
pubmed: 15145993
Neurology. 2004 Nov 23;63(10):1898-901
pubmed: 15557508
Neuroimage. 2004 Oct;23(2):764-75
pubmed: 15488426
Int J Alzheimers Dis. 2011 Feb 24;2011:726197
pubmed: 21423560
Neuropsychology. 2019 Mar;33(3):406-416
pubmed: 30730162
Alzheimers Dement. 2008 Jul;4(4):251-4
pubmed: 18631975
Neurotoxicology. 2017 Jul;61:143-187
pubmed: 28363508
Psychol Aging. 2016 Mar;31(2):166-75
pubmed: 26796792

Auteurs

Sheida Rabipour (S)

Centre for Cerebral Imaging, Douglas Hospital Research Centre, Montreal, Canada.
Department of Psychiatry, McGill University, Montreal, Canada.

Sricharana Rajagopal (S)

Centre for Cerebral Imaging, Douglas Hospital Research Centre, Montreal, Canada.

Elsa Yu (E)

Integrated Program in Neuroscience, McGill University, Montreal, Canada.

Stamatoula Pasvanis (S)

Centre for Cerebral Imaging, Douglas Hospital Research Centre, Montreal, Canada.

Marie-Elyse Lafaille-Magnan (ME)

Department of Psychiatry, McGill University, Montreal, Canada.
Center for Studies on Prevention of Alzheimer's Disease, Montreal, Canada.
Lady Davis Center for Medical Research, Jewish General Hospital, Montreal, Canada.

John Breitner (J)

Centre for Cerebral Imaging, Douglas Hospital Research Centre, Montreal, Canada.
Center for Studies on Prevention of Alzheimer's Disease, Montreal, Canada.

M Natasha Rajah (MN)

Centre for Cerebral Imaging, Douglas Hospital Research Centre, Montreal, Canada.
Department of Psychiatry, McGill University, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH